EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Liquid Chromatography Tandem Mass Spectrometry Method for the Simultaneous Estimation of the Dopamine Receptor Antagonist LE300 and Its N-methyl Metabolite in Plasma: Application to a Pharmacokinetic Study

Mohamed M Hefnawy, Mohamed W Attwa iD, Adeeba A Alzamil, Manal A El-Gendy, Adel S El-Azab, Yousef A Bin Jardan iD, Ali A El-Gamal iD

Molecules · 2023

DOI: 10.3390/molecules28041553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Mohamed M Hefnawy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Dopamine Antagonists. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deputyship for Research & Innovation, "Ministry of Education" in Saudi Arabia, Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

LE300 is a novel dopamine receptor antagonist used to treat cocaine addiction. In the current study, a sensitive and fast liquid chromatography–tandem mass spectrometry (LC-MS/MS) has been established and validated for the simultaneous analysis of LE300 and its N-methyl metabolite, MLE300, in rat plasma with an application in a pharmacokinetic study. The chromatographic elution of LE300, MLE300, and Ponatinib (IS, internal standard), was carried out on a 50 mm C18 analytical column (ID: 2.1 mm and particle size: 1.8 μm) maintained at 22 ± 2 °C. The run time was 5 min at a flow rate of 0.3 mL/min. The mobile phase consisted of 42% aqueous solvent (10 mM ammonium formate, pH: 4.2 with formic acid) and 58% organic solvent (acetonitrile). Plasma samples were pretreated using protein precipitation with acetonitrile. The electrospray ionization (ESI) source was used to generate an ion-utilizing positive mode. A multiple reaction monitoring mass analyzer mode was utilized for the quantification of analytes. The linearity of the calibration curves in rat plasma ranged from 1 to 200 ng/mL (r2 = 0.9997) and from 2 to 200 ng/mL (r2 = 0.9984) for LE300 and MLE300, respectively. The lower limits of detection (LLOD) were 0.3 ng/mL and 0.7 ng/mL in rat plasma for LE300 and MLE300, respectively. Accuracy (RE%) ranged from −1.71% to −0.07% and −4.18% to −1.48% (inter-day), and from −3.3% to −1.47% and −4.89% to −2.15% (intra-day) for LE300 and MLE300, respectively. The precision (RSD%) was less than 2.43% and 1.77% for the inter-day, and 2.77% and 1.73% for intra-day of LE300 and MLE300, respectively. These results are in agreement with FDA guidelines. The developed LC-MS/MS method was applied in a pharmacokinetic study in Wistar rats. Tmax and Cmax were 2 h and 151.12 ± 12.5 ng/mL for LE300, and 3 h and 170.4 ± 23.3 ng/mL for MLE300.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryDopamine AntagonistsRatsAnimalsChromatography, LiquidChromatography, High Pressure LiquidRats, WistarReproducibility of Results

Stichwörter der Autor:innen

LC-MS/MSLE300N-methyl metabolitepharmacokinetic study

Substanzen

Dopamine Antagonists

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
  • Department of Analytical Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
  • Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
  • Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.

ORCID-Profile: Mohamed W Attwa, Yousef A Bin Jardan, Ali A El-Gamal

Förderung

  • Deputyship for Research & Innovation, "Ministry of Education" in Saudi Arabia
  • Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia

Zitieren

APA

Hefnawy, M. M., Attwa, M. W., Alzamil, A. A., El-Gendy, M. A., El-Azab, A. S., Jardan, Y. A. B., & El-Gamal, A. A. (2023). A Liquid Chromatography Tandem Mass Spectrometry Method for the Simultaneous Estimation of the Dopamine Receptor Antagonist LE300 and Its N-methyl Metabolite in Plasma: Application to a Pharmacokinetic Study. Molecules. https://doi.org/10.3390/molecules28041553

Vancouver

Hefnawy MM, Attwa MW, Alzamil AA, El-Gendy MA, El-Azab AS, Jardan YAB, et al. A Liquid Chromatography Tandem Mass Spectrometry Method for the Simultaneous Estimation of the Dopamine Receptor Antagonist LE300 and Its N-methyl Metabolite in Plasma: Application to a Pharmacokinetic Study. Molecules. 2023. doi:10.3390/molecules28041553

BibTeX
@article{Hefnawy2023,
  author = {Hefnawy, Mohamed M and Attwa, Mohamed W and Alzamil, Adeeba A and El-Gendy, Manal A and El-Azab, Adel S and Jardan, Yousef A Bin and El-Gamal, Ali A},
  title = {A Liquid Chromatography Tandem Mass Spectrometry Method for the Simultaneous Estimation of the Dopamine Receptor Antagonist LE300 and Its N-methyl Metabolite in Plasma: Application to a Pharmacokinetic Study},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28041553}
}
Kostenlos starten →